image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Synergy Health - Offer triggers gains of 875%

December 2014

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • SYR
  • Price:
  • 1950p
Synergy has accepted a take-over offer from US-based medical technology firm, Steris, worth £19.50 a share, a 39% premium to Synergy’s closing level that day. Steris will pay Synergy shareholders 439p in cash and 0.4308 Steris shares valuing Synergy at around £1.18bn.The deal represents a useful 27% premium to Synergy’s previous high of 1530p in September and based on N+1 Singer’s forecast, values it at 26.4 times current year earnings.We originally made the shares a main write-up at 200p in July ‘03 and again at 399p in December ‘04 while we also added them to the Trader Portfolio at 226p. That makes for gains of as high as 875% - a magnificent performance! Accept the offer. ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X